Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer

NCT02188264 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Recurrent Colorectal Carcinoma
Solid Neoplasm
Stage IIIA Colorectal Cancer AJCC v7
Stage IIIB Colorectal Cancer AJCC v7
Stage IIIC Colorectal Cancer AJCC v7
Stage IVA Colorectal Cancer AJCC v7
Stage IVB Colorectal Cancer AJCC v7

Interventions

DRUG: Cyclosporine
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
DRUG: Selumetinib

Sponsor

National Cancer Institute (NCI)